PreveCeutical Medical Inc. (CSE:PREV)
Canada
· Delayed Price · Currency is CAD 0.0300
-0.0050 (-14.29%)
Jun 27, 2025, 11:45 AM EDT
PreveCeutical Medical Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -1.7 | -1.17 | -1.27 | -1.48 | -1.73 | -3.8 | Upgrade
|
Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.08 | Upgrade
|
Other Amortization | - | - | - | - | - | 0 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | -0 | 0 | 0.08 | Upgrade
|
Stock-Based Compensation | 0.21 | 0.08 | 0.13 | 0.33 | 0.09 | 1.17 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | 0.04 | - | - | Upgrade
|
Other Operating Activities | 0.32 | 0.32 | 0.31 | 0.38 | 0.61 | 1.84 | Upgrade
|
Change in Accounts Receivable | -0.03 | -0.02 | 0.01 | -0 | 0.04 | 0.01 | Upgrade
|
Change in Accounts Payable | 0.71 | 0.34 | 0.53 | 0.52 | 0.55 | 0.49 | Upgrade
|
Change in Other Net Operating Assets | 0.01 | 0.03 | -0.02 | -0.03 | 0.01 | 0.21 | Upgrade
|
Operating Cash Flow | -0.47 | -0.43 | -0.3 | -0.22 | -0.43 | 0.06 | Upgrade
|
Capital Expenditures | -0 | -0 | - | - | - | - | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | 0 | 0 | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.06 | - | - | - | -0.06 | -0 | Upgrade
|
Investing Cash Flow | -0.06 | -0 | - | 0 | -0.05 | -0 | Upgrade
|
Short-Term Debt Issued | - | 0.32 | 0.29 | 0.22 | 0.19 | 0.06 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 0.09 | 0.17 | Upgrade
|
Total Debt Issued | 0.32 | 0.32 | 0.29 | 0.22 | 0.28 | 0.23 | Upgrade
|
Short-Term Debt Repaid | - | -0.07 | - | - | -0.14 | -0.01 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | - | -0.04 | Upgrade
|
Total Debt Repaid | -0.07 | -0.07 | - | - | -0.14 | -0.05 | Upgrade
|
Net Debt Issued (Repaid) | 0.25 | 0.25 | 0.29 | 0.22 | 0.14 | 0.18 | Upgrade
|
Issuance of Common Stock | 0.29 | 0.24 | - | - | - | 0 | Upgrade
|
Other Financing Activities | - | - | - | -0.01 | - | - | Upgrade
|
Financing Cash Flow | 0.54 | 0.49 | 0.29 | 0.21 | 0.14 | 0.18 | Upgrade
|
Foreign Exchange Rate Adjustments | -0 | -0 | -0 | -0 | 0.2 | -0.12 | Upgrade
|
Net Cash Flow | 0 | 0.06 | -0 | -0.01 | -0.14 | 0.13 | Upgrade
|
Free Cash Flow | -0.47 | -0.43 | -0.3 | -0.22 | -0.43 | 0.06 | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | - | -0.00 | - | Upgrade
|
Cash Interest Paid | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | Upgrade
|
Levered Free Cash Flow | -0.15 | -0.25 | -0.1 | -0.25 | -0.29 | -0.02 | Upgrade
|
Unlevered Free Cash Flow | 0.05 | -0.04 | 0.1 | -0.1 | 0 | 0.38 | Upgrade
|
Change in Net Working Capital | -0.69 | -0.34 | -0.53 | -0.21 | -0.48 | -0.45 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.